BDNF and schizophrenia: Consequently, reduced BDNF levels at the onset of psychosis indicate its potential role in the pathogenesis of schizophrenia and suggest that it could serve as a valuable neurobiological marker for early treatment interventions targeting NMDA receptor pathways.